HPS Pharmacies wish to give notice that Pfizer Australia Pty Ltd are currently experiencing an interruption to the supply of Isuprel™ as follows:
Normal supplies are expected to resume in late August, 2017. While wholesaler stocks of Isuprel™ ampoules are exhausted, HPS Pharmacies are still able to source a limited supply for the benefit of our clients.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 675 229.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.